Relmada Therapeutics (RLMD) Depreciation & Amortization (CF) (2013 - 2021)
Relmada Therapeutics (RLMD) posted Depreciation & Amortization (CF) of $1,258 for FY2021, down 66.5% from $3,752 in FY2020.
Powered by 
Analysis
Relmada Therapeutics (RLMD) Depreciation & Amortization (CF) (2013 - 2021) Analysis & Trends
Since FY2013, Relmada Therapeutics has reported Depreciation & Amortization (CF) for 9 years.
- Annual Depreciation & Amortization (CF) shows a five-year compound annual growth rate of -53.0% (FY2016 to FY2021).
- The FY2021 figure stands as the lowest annual Depreciation & Amortization (CF) since FY2013.
- Business Quant data shows RLMD's Depreciation & Amortization (CF) at $3,752 in FY2020 (-14.0%), $4,363 in FY2019, $2,627 in FY2018 (-96.9%) and $85,271 in FY2017 (+55.6%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 545.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.12 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 192.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 726.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 1.61 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 1.12 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 132.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.58 Bn |
| 10 | Relmada Therapeutics | 455.48 Mn | -103.11 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2021 | -1.30 Mn |
| Jun 30, 2021 | 452.00 |
| Mar 31, 2021 | 806.00 |
| Dec 31, 2020 | 823.00 |
| Sep 30, 2020 | -2.10 Mn |
| Jun 30, 2020 | 1,029.00 |
| Mar 31, 2020 | 1,046.00 |
| Dec 31, 2019 | -1,582.00 |
| Sep 30, 2019 | 1,100.00 |
| Mar 31, 2019 | 1,075.00 |
| Dec 31, 2018 | 1,607.00 |
| Sep 30, 2018 | 1,405.00 |
| Jun 30, 2018 | 929.00 |
| Mar 31, 2018 | 568.00 |
| Dec 31, 2017 | 582.00 |
| Sep 30, 2017 | 548.00 |
| Jun 30, 2017 | 18,259.00 |
| Mar 31, 2017 | 23,268.00 |
| Dec 31, 2016 | 23,581.00 |
| Sep 30, 2016 | 20,163.00 |
API Access
Relmada Therapeutics Depreciation & Amortization (CF) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=RLMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "depreciation-and-amortization-cf", "ticker": "RLMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=RLMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();